您好, 歡迎來(lái)到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司>>藥物雜質(zhì)對(duì)照品>>雜質(zhì)>> 利格列汀雜質(zhì) 利拉利汀雜質(zhì)
產(chǎn)品型號(hào)
品 牌其他品牌
廠商性質(zhì)生產(chǎn)商
所 在 地深圳市
更新時(shí)間:2022-03-17 15:16:26瀏覽次數(shù):1435次
聯(lián)系我時(shí),請(qǐng)告知來(lái)自 化工儀器網(wǎng)奧美拉唑雜質(zhì) 對(duì)照品標(biāo)準(zhǔn)品
莫西沙星雜質(zhì) 對(duì)照品標(biāo)準(zhǔn)品
伊馬替尼雜質(zhì) 對(duì)照品標(biāo)準(zhǔn)品
依折麥布雜質(zhì) 對(duì)照品標(biāo)準(zhǔn)品
利格列汀雜質(zhì) 利拉利汀雜質(zhì)?? 產(chǎn)品介紹:
規(guī)格:10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途:實(shí)驗(yàn)研發(fā),藥品申報(bào)檢測(cè),不得用于臨床醫(yī)學(xué)診斷。
隨貨提供:所有雜質(zhì)對(duì)照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書(shū)。
國(guó)產(chǎn)進(jìn)口品牌皆有銷(xiāo)售,產(chǎn)品庫(kù)時(shí)常更新,部分雜質(zhì)長(zhǎng)期備有庫(kù)存,可當(dāng)天發(fā)貨,另外,我司有專業(yè)研發(fā)團(tuán)隊(duì),可提供雜質(zhì)定制服務(wù),以zui大可能的滿足您對(duì)雜質(zhì)對(duì)照品的選購(gòu)需求。
利格列汀雜質(zhì) 利拉利汀雜質(zhì)?? 雜質(zhì)列表:
Linagliptin | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 1 | 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 2 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
Linagliptin Impurity 3 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 4 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 5 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
Linagliptin Impurity 6 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
Linagliptin Impurity 7 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
Linagliptin Impurity 8 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide |
Linagliptin Impurity 9 | 8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 10 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 11 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 12 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 13 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 14 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 15 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 16 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
Linagliptin Impurity 17 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 18 | 7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 19 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
Linagliptin Impurity 20 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 21 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
Linagliptin Impurity 22 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 23 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 24 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 25 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 26 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
?? 我司主營(yíng)醫(yī)藥標(biāo)準(zhǔn)品及雜質(zhì)對(duì)照品,以下雜質(zhì)備有庫(kù)存,可當(dāng)天發(fā)貨,*: 依魯替尼雜質(zhì),奧貝膽酸雜質(zhì),依美斯汀雜質(zhì),卡格列凈雜質(zhì),利格列汀雜質(zhì),西格列汀雜質(zhì),埃索美拉唑雜質(zhì),LCZ696雜質(zhì),恩雜魯胺雜質(zhì),艾曲波帕雜質(zhì),非布司他雜質(zhì),托匹司他雜質(zhì),樂(lè)伐替尼雜質(zhì),奧拉帕尼雜質(zhì),阿維巴坦雜質(zhì),奧美拉唑雜質(zhì),普卡必利雜質(zhì),西他沙星雜質(zhì),泊沙康唑雜質(zhì),替格瑞洛雜質(zhì),托法替尼雜質(zhì),決奈達(dá)隆雜質(zhì),阿奇霉素雜質(zhì)等。
?? 美國(guó)劍橋CIL標(biāo)準(zhǔn)品部分產(chǎn)品列表:
DLM-277-PK HEXANOIC ACID (D11, 98%)
CLM-9146-0.01 5-ALPHA-DIHYDROTESTOSTERONE 97% CHEMICAL PURITY (2,3,4-13C3,99%)
EDF-4143-1 CALIBRATION CURVE, CDC1 DIOXIN, FURAN, & PCB IN TISSUE IN NONANE
JR-D45-25 1,2,4,6,7,9-HEXACDD UNLABELED ~25 NG/ML IN NONANE
CGM-1000-CN-20-S BIOEXPRESS CELL GROWTH MEDIA (U-13C, 19%; U-15N, 98%) (10X CONCENTRATE)
DLM-2084-PK L-DOPA (RING-D3, 98%)
H-922 ALPHA-HYDROXYMIDAZOLAM UNLABELED 1.0 MG/ML IN METHANOL
CRLM-4396-0 CHROMIUM-54 OXIDE (54Cr)
CLM-1896-PK INDOLE-3-ACETIC ACID (PHENYL-13C6, 99%)
H-049 HYDROMORPHONE (D6, 98%) 100 UG/ML IN METHANOL
EC-5000 WHO COPLANAR & MONO-ORTHO PCB + PCB-170 & PCB-180 UNLABELED 2 UG/ML IN ISOOCTANE
CDLM-7754-PK SUCCINIC ACID (13C4, 99%; 2,2,3,3-D4, 98%)
DLM-143-5X1 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL-D2 (D, 98%)
PCB-170-C 2,2',3,3',4,4',5-HEPTACB UNLABELED
CLM-3876-PK SODIUM OCTANOATE (1,2,3,4-13C4, 99%)
CNLM-6696-PK CELL FREE AMINO ACID MIX (20 AA) (U-13C, 97-99%+; U-15N, 97-99%)
ES-5038-1-10X-1 CLP VOLATILES NON-KETONE DMC 10X STOCK SOLUTION 1000 UG/ML IN METHANOL-OD
EC-1436-1.2 2,2',3,4,4',5'-HEXACB (PCB-138) (13C12, 99%) 40+/-2 UG/ML IN NONANE
CLM-2093-MPT-PK ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED
DLM-10-PK DIMETHYL SULFOXIDE-D6 (D, 99.9%)
EDF-5429-CS8H TWO COLUMN DIOXIN & FURAN CALIBRATION SOLUTION CS8H (UNLABELED/13C12, 99%)
CLM-156-MPT-PK SODIUM ACETATE (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED
DLM-6196-1.2 METHYLPHOSPHONIC ACID (METHYL-D3, 98%) 100 UG/ML IN METHANOL
CLM-2456-PK D-XYLOSE (1,2-13C2, 99%)
PCB-166-C 2,3,4,4',5,6-HEXACB UNLABELED
CDLM-7582-SL-1 HIS-UBIQUITIN DC (13C, 98%; D, 98%) *DISCONTINUED*
ULM-9091-1.2 TRIPHENYL PHOSPHATE UNLABELED 1 MG/ML IN ACETONITRILE
DLM-4721-0.5 L-CYSTEINE-N-FMOC, S-TRITYL (3,3-D2, 98%)
更多關(guān)于 ?? 的產(chǎn)品信息,請(qǐng)我司獲取詳情~
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn),建議您在購(gòu)買(mǎi)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。